Patients' and relatives' assessment of clozapine treatment

  title={Patients' and relatives' assessment of clozapine treatment},
  author={Matthias C. Angermeyer and Walter L{\"o}ffler and Peter M{\"u}ller and Beate M. Schulze and Stefan Priebe},
  journal={Psychological Medicine},
  pages={509 - 517}
Background. Subjective evaluations by schizophrenic patients and their relatives of clozapine treatment were assessed as part of an exploratory study. Methods. A problem-centred interview was carried out with 80 patients at discharge from in-patient or day-hospital treatment. Views of 46 relatives on the treatment were also assessed. Results. In addition to expected effects (improvement of or stabilisation of one's state of mental health, antipsychotic effects), patients surprisingly often… 

Patients with schizophrenia found that clozapine improved their wellbeing without resulting in extrapyramidal motor side effects

  • H. Pal
  • Medicine, Psychology
  • 2001
Patients' and relatives' assessment of clozapine treatment and improved sleeping patterns and felt calmer, more relaxed, and more balanced.

Attitude towards and experience with clozapine of patients and their caregivers after three months of starting of clozapine

It is suggested that a significant proportion of patients receiving clozapine for three months and their relatives report positive perception and experience with the molecule.

Psychiatrists’ attitude towards and knowledge of clozapine treatment

It is believed that patients treated with clozapine were less satisfied with their treatment when compared with those treated with other atypical antipsychotics, and many psychiatrists are reluctant to use clozAPine and this might be due to less experience and knowledge of clozabine.

Side-effects and treatment with clozapine: a comparison between the views of consumers and their clinicians.

It is suggested that despite significant side-effects and regular blood tests, most stable consumers taking clozapine were happier and more satisfied with their treatment than many of their clinicians believed they were.

A Questionnaire-based Study of the Views of Schizophrenia Patients and Psychiatric Healthcare Professionals in Japan about the Side Effects of Clozapine

  • Ippei TakeuchiManako Hanya Hiroyuki Kamei
  • Medicine, Psychology
    Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
  • 2016
Patients with schizophrenia and psychiatric healthcare professionals in Japan treated with clozapine experienced more problems than healthcare professionals expected, and it is necessary that all healthcare professionals fully understand the efficacy and potential side effects of clozAPine.

An evaluation of subjective experiences, effects and overall satisfaction with clozapine treatment in a UK forensic service

The subjective effects of clozapine treatment should be taken into account by clinicians when assessing response and may provide an opportunity to highlight the positive changes and prioritize management of the most undesirable adverse effects, which is likely to promote compliance and improve longer term treatment outcomes.

Subjective Meaning of Taking Antipsychotic Medication for Patients with Schizophrenia in Japan

In the current study, 11 schizophrenic and schizo-affective patients were interviewed to elicit the participants' subjective opinions about their medicines, and adherent patients tried to make sense of taking antipsychotics by covering negative meanings with positive ones.

What side effects are problematic for patients prescribed antipsychotic medication? The Maudsley Side Effects (MSE) measure for antipsychotic medication

The Maudsley Side Effects measure is a self-report questionnaire that identifies reliably the side-effect burden as experienced by patients, and can act as a starting point for joint decision making on the type and the dose of medication.



Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia.

Clozapine has superior efficacy for treating positive symptoms in partially responsive outpatients with chronic schizophrenia, suggesting that it has utility for a broad spectrum of patients with schizophrenia beyond the most severely ill.

Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia.

Clozapine produced a marked improvement in Brief Psychiatric Rating Scale total scores as well as positive negative symptom scores, Global Assessment scale scores, Quality of Life Scale scores, work functioning, capacity for independent living, and rehospitalization rates.

A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables

  • D. Naber
  • Psychology, Medicine
    International clinical psychopharmacology
  • 1995
Data indicate that the SWN is a useful tool for investigating a hitherto neglected psychopathological dimension in schizophrenic patients, and should be considered more thoroughly in clinical routine as well as in clinical trials of potential neuroleptic drugs.

Subjective utility ratings of neuroleptics in treating schizophrenia

The subjective utility of neuroleptic medications for schizophrenia is most justifiable from an institutional perspective, and side effects are significantly less bothersome than symptoms when considering costs to society.

Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients.

The effect of approximately six months of treatment with clozapine on the quality of life of 38 treatment-resistant schizophrenic patients was prospectively studied in an open trial and ratings tended to be negatively correlated with ratings on the Brief Psychiatric Rating Scale at baseline and at six months.

[Etiology of schizophrenia from the viewpoint of the patient].

According to a quantitative study on causal beliefs patients with functional psychoses favour psychosocial over biological explanations and tend to endorse a multicausal concept, a contrast with the results of psychiatric research on the causes of schizophrenia.

Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.

Clozapine therapy, performed in conjunction with close haematological monitoring, is indicated for the management of severe and chronic schizophrenia refractory to classic antipsychotic therapy, and in those unable to tolerate such therapy.

Effects of Clozapine ,

Clozapine seems to influence striatal DA by a mechanism other than DA-receptor blockade, and there was no correlation between the effects on NA-metabolism and the EEG-arousal inhibitory activities of these agents or their clinical antipsychotic effects.

Schizophrenic patients' experiences of neuroleptic medication: a Q‐methodological investigation

Schizophrenic patients' experiences of neuroleptic medication: a Q‐methodological investigation suggests a need for further research into the role of language in the treatment of schizophrenia.

The Focused Interview

The focused interview is designed to determine the responses of persons exposed to a situation previously analyzed by the investigator. Its chief functions are to discover: (1) the significant